Sequential chemo best in metastatic breast cancer

Combination chemotherapy does not provide a survival benefit to women with metastatic breast cancer compared with sequential therapy, an Australian-authored Cochrane review finds.

In fact, combination therapy carried a 16% higher risk of disease progression – a result that remained consistent across a number of subgroups, according to the analysis of 12 trials and over 2,300 patients.

Although there were higher overall tumour response rates with combination therapy there was significant heterogeneity

Latest

Trending